Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Gene|June 3, 1997
Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regionsL H Butterfield, T C Stoll, R Lau, et al.Molecular Immunology|June 8, 2001
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoproteinW S Meng, L H Butterfield, A Ribas, et al.Human Gene Therapy|February 4, 1998
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2L A Bui, L H Butterfield, J Y Kim, et al.Cancer Research|July 9, 1999
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoproteinL H Butterfield, A Koh, W Meng, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL culturesP J Frost, L H Butterfield, V B Dissette, et al.Cancer Research|December 26, 2001
alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccinationW S Meng, L H Butterfield, A Ribas, et al.Anticancer Research|June 16, 1999
Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicitiesA Ribas, L A Bui, L H Butterfield, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2001
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoproteinL H Butterfield, W S Meng, A Koh, et al.Cancer Gene Therapy|December 23, 1999
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cellsA Ribas, L H Butterfield, W H McBride, et al.Pageof 19